Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate-ammonia ligase pseudogene 3 (GLULP3) is a genomic DNA sequence in humans that represents a nonfunctional copy (pseudogene) of the gene encoding glutamate-ammonia ligase (glutamine synthetase). Unlike the active enzyme, pseudogenes such as GLULP3 lack the ability to encode a functional protein due to disabling mutations, deletions, or rearrangements. Pseudogenes may have regulatory functions at the RNA level but generally do not serve as drug targets or have major biological roles. There is no evidence that GLULP3 encodes an active receptor, transporter, or enzyme, nor is it linked to any diseases, drug action, or clinical biomarker use[3]. GLULP3 should not be confused with the functional **glutamate-ammonia ligase (GLUL)** enzyme, which does play significant biological roles in nitrogen metabolism. The presence of "pseudogene" in its name indicates that this specific entry is non-functional with respect to its protein-coding potential[3].
Not applicable; as a pseudogene, there is no mechanism of action for drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-ammonia ligase pseudogene 3 (GLULP3).